Flies that expressed an Alzheimer’s disease-related protein in their neurons showed signs of accelerated aging.

UCLA researchers have developed a drug that counteracts the impaired cognition caused by Alzheimer’s disease and reestablishes brain connections following strokes in mice. The team began ...

The lumipulse blood test brings renewed hope for earlier diagnosis and treatment for millions of people facing the uncertainty of Alzheimer's disease and other dementias.

A blood test that can help diagnose Alzheimer’s disease has received clearance from the Food and Drug Administration. This is a step toward a goal of scientists and doctors to one day be able to ...

As we age, neurocognitive disorders, including dementia and Alzheimer’s disease, can be particularly worrisome, impacting not just the individual but also their loved ones. Understanding the ...

Up to 8 in 10 Americans carry a common viral infection that may raise the risk of developing Alzheimer’s disease, new research suggests.

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase access to Alzheimer’s detection and reduce reliance on expensive ...

In an unprecedented large-scale study, researchers have mapped out the first molecular events that cause harmful protein buildups in the brain of people with Alzheimer's disease.

At least 22 viruses have been tied to Alzheimer's, dementia, or other neurodegenerative diseases, and some researchers have proposed that latent viral infection may provoke Alzheimer's disease.

TB006 is a new investigational drug could have the potential of treating Alzheimer's disease and reversing the effects.

A new study links cold sores to Alzheimer's, highlighting HSV-1's role. Women in particular could have a higher risk. Anti-herpetic drugs may reduce dementia chances.

In a small pilot trial published in a journal, researchers found that creatine monohydrate may help improve cognitive function in individuals with Alzheimer's Disease.